The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

The nuclei in our cells are miniature warehouses safeguarding the genetic blueprint for the body's biologic machinery. As ...

MT-601, Marker's lead MAR-T cell therapy, is being evaluated in the nationwide multicenter Phase 1 APOLLO study ( clinicaltrials.gov identifier: NCT05798897) in patients with anti-CD19 CAR-T relapsed ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

Mouse study reveals beneficial bacteria play crucial role in helping insulin-producing cells multiply. Exposure to ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...

Alongside this research, other studies have shown that lifestyle choices can also help manage diabetes. Eating more whole ...

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the ...

Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice ...